Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: A pilot study

AIM: Various side effects have been reported in patients infected with hepatitis C virus (HCV) who were treated with interferon-alpha (IFN-α), including the appearance or exacerbation of underlying autoimmune diseases and the development of a variety of organ and non-organ specific autoantibodies (N...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:World J Gastroenterol
Autores principales: Gatselis, Nikolaos K., Georgiadou, Sarah P., Tassopoulos, Nikolaos, Zachou, Kalliopi, Liaskos, Christos, Hatzakis, Angelos, Dalekos, Georgios N.
Formato: Artigo
Lenguaje:Inglês
Publicado: Baishideng Publishing Group Inc 2005
Materias:
Viral Hepatitis
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4250795/
https://ncbi.nlm.nih.gov/pubmed/15641130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v11.i4.482
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares